Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-19

FDA Approved: LATANOPROST — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for a generic latanoprost product from Sandoz Inc., enabling its market availability. The approval covers a generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

SUPPL AP for LATANOPROST (LATANOPROST)